2/20 #TumorBoardTuesday
What if pt had de novo high volume mCSPC?

💡Mini tweetorial 1
2 recent “triplet therapy” options for pts:

1.📚PEACE-1 trial
ADT + doce vs ADT + doce + abiraterone
Low-volume: no OS benefit to abi
High-volume OS: 3.47 years w/o abi vs 5.14 years w/ abi 🏆
#TumorBoardTuesday